Sun Pharma Q4 Results: India's largest drugmaker reports net profit of Rs 1,985 crore

Sun Pharma, India's largest drugmaker, on Friday, reported a consolidated net profit of Rs 1,984.47 crore for the quarter ended March 31, 2023, against a loss of Rs 2,277.25 crore in the same period last year. The profit was, however, lower sequentially as it stood at Rs 2,166.01 crore in Q3FY23. The revenue for the reporting quarter came in at Rs 10,726 crore, up 12% year-on-year (YoY) as against Rs 9,560 crore in Q4FY22.

► For business news on the go, download ET app:

Follow ET on:

#news #latestnews #economictimes #ET #TheEconomicTimes #businessnews